ChemicalBook >> CAS DataBase List >>NBI 6024

NBI 6024

CAS No.
239480-61-6
Chemical Name:
NBI 6024
Synonyms
NBI 6024;Glycine, L-seryl-L-histidyl-L-leucyl-L-valyl-L-alpha-glutamyl-L-alanyl-L-leucyl-L-alanyl-L-leucyl-L-valyl-L-alanylglycyl-L-alpha-glutamyl-L-arginyl-
CBNumber:
CB32451322
Molecular Formula:
C66H112N20O21
Molecular Weight:
1521.73
MDL Number:
MFCD09837858
MOL File:
239480-61-6.mol
TDS File:
TDS
Last updated:2026-04-24 14:58:57

NBI 6024 Properties

FDA UNII OMF3CT7D4L

NBI 6024 price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
aablocks AA00BX4X NBI 6024 ≥95% 239480-61-6 1mg $167 2026-05-28 Buy
aablocks AA00BX4X NBI 6024 ≥95% 239480-61-6 5mg $393 2026-05-28 Buy
aablocks AA00BX4X NBI 6024 ≥95% 239480-61-6 10mg $543 2026-05-28 Buy
American Custom Chemicals Corporation API0019355 L-SERYL-L-HISTIDYL-L-LEUCYL-L-VALYL-L-A-GLUTAMYL-L-ALANYL-L-LEUCYL-L-ALANYL-L-LEUCYL-L-VALYL-L-ALANYLGLYCYL-L-A-GLUTAMYL-L-ARGINYL-GLYCINE 95.00% 239480-61-6 5MG $504.78 2021-12-16 Buy
Product number Packaging Price Buy
AA00BX4X 1mg $167 Buy
AA00BX4X 5mg $393 Buy
AA00BX4X 10mg $543 Buy
API0019355 5MG $504.78 Buy

NBI 6024 Chemical Properties, Uses, Production

Uses

NBI-6024, an altered peptide ligand (APL), is an epitope recognized by inflammatory interferon-gamma-producing T helper lymphocytes in type 1 diabetic patients[1][2].

in vivo

NBI-6024 (0.005-20 mg/kg, s.c.) delays the onset and reduces the incidence of diabetes in mice[2].

Animal Model:Nonobese diabetic (NOD) mice[2]
Dosage:0.005, 0.05, 0.5, 5, 10, 20 mg/kg
Administration:Subcutaneous injection (s.c.)
Result:Observed dose-dependent induction of responsiveness to the immunizing antigen at 5, 10, 20 mg/kg (tested by culturing spleen cells pooled from mice).

References

[1] D G Alleva et al. Immunomodulation in type 1 diabetes by NBI-6024, an altered peptide ligand of the insulin B epitope. Scand J Immunol. 2006 Jan;63(1):59-69. DOI:10.1111/j.1365-3083.2005.01705.x
[2] Alleva DG, et al. Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide. Diabetes. 2002 Jul;51(7):2126-34. DOI:10.2337/diabetes.51.7.2126

NBI 6024 Preparation Products And Raw materials

Raw materials

Preparation Products

NBI 6024 Suppliers

Global Suppliers ( 3)
Supplier Tel Email Country ProdList Advantage
Shanghai HongTide Biotechnology Co.,Ltd. 15318089928 alex@hanhonggroup.com China 4604 58
TargetMol Chemicals Inc. 15002134094 marketing@targetmol.cn China 29874 58
YantaiBio 13758194781; 13758194781 764619768@qq.com China 1755 58
NBI 6024 Glycine, L-seryl-L-histidyl-L-leucyl-L-valyl-L-alpha-glutamyl-L-alanyl-L-leucyl-L-alanyl-L-leucyl-L-valyl-L-alanylglycyl-L-alpha-glutamyl-L-arginyl- 239480-61-6